Shaping a Generation Through Dialogue: Inside the Doha Debates Ambassador Program

Submitted by Anonyme on 2026-07-20T14:15:01+02:00
In a world shaped by change and competing narratives, the ability to listen, question and engage in constructive dialogue has never been more critical. Through the Doha Debates Ambassador Program, a production of Qatar Foundation, young people from around the world are not only learning these skills, but actively...
Anglais

HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong

Submitted by Anonyme on 2026-07-20T14:15:01+02:00
HistoSonics today announced the opening of its expanded Histotripsy Training Center in Hong Kong, reinforcing the city's position as a leading hub for physician education...
Anglais

Epic Flight Academy Agrees to Purchase up to 50 Pipistrel Voyager Aircraft, Supplementing Its Fleet of Trainers as It Supports Continued Pilot Training

Submitted by Anonyme on 2026-07-20T18:15:01+02:00
Pipistrel, a Textron Inc. (NYSE: TXT) company and an affiliate of Textron Aviation Inc., today announcedEpic Flight Academyas the launch customer for the Pipistrel Voyager during Textron Aviation’s press conference at EAA AirVenture 2026. The company has signed a purchase agreement for up to 50 Voyager aircraft, with an order for 10 initial deliveries beginning in 2027, and options for up to 20 additional aircraft in 2028 and 20 in...
Anglais

Hollywood Chamber of Commerce Expands Into Luxury Hospitality

Submitted by Anonyme on 2026-07-20T19:15:01+02:00
The Hollywood Chamber of Commerce, known for the iconic Hollywood Sign®and Hollywood Walk of Fame®, is expanding into luxury hospitality through a strategic partnership withThe Scene Hotels...
Anglais

Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension

Submitted by Anonyme on 2026-07-20T22:15:02+02:00
Brenus Pharma today announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution across clinical, regulatory, and business development milestones, de-risking STC-1010(NCT06934538): lead clinical-stage in-vivo immunotherapy for MSS...
Anglais
Subscribe to